Assessing Treatments Effects in Multi-Center Clinical Trials with Application To Scleroderma Lung Study: A Semiparametric Bayesian Approach

38 Pages Posted: 6 Aug 2012

See all articles by Man-Wai Ho

Man-Wai Ho

National University of Singapore (NUS)

Pulak Ghosh

Indian Institute of Management (IIMB), Bangalore

Robert Elasoff

University of California, Los Angeles (UCLA)

Ram Tiwari

Government of the United States of America - Food and Drug Administration (FDA)

Date Written: September 11, 2009

Abstract

In this article we explore the testing of non-inferiority and equivalence hypotheses arising from multiple centers when the assumption of normality is violated. In a multicenter study, the trials are typically conducted at different centers which vary in terms of location, environment, demographics among others, leading to substantial amount of heterogeneity in the patient population. This unexplained variation in a multi-center clinical study is usually modeled using a random effects model, where the centers are assumed to be a random sample from the population of centers. Most research in this direction uses a parametric normal distribution which can be restrictive and may lead to biased result if the actual distribution is nonnormal. In this article, we overcome this parametric assumption by considering a broader class of random effects distribution for the centers. In particular, we develop a novel nested Dirichlet process (nDP) model to explore the sensitivity of the fixed treatment effects under various hypotheses, in the presence of nonnormality. Additional advantage of our proposed method is that it facilitates a hierarchical clustering structure. At one hand it clusters the centers according to their effects, and hence outlying centers can be identified. Simultaneously, subjects from the clustered centers are again clustered together enabling a borrowing of information across similar centers. Further, we present the methodology to test between the models with nDP versus a normal random center effects models. We discuss the results of our proposed methodology in a real example of a multi-center clinical trial on Scleroderma lung study. The results of the analysis along with the extensive simulation study show the advantage of our method when the center effects distribution is not normal.

Keywords: treatment effect, nested Dirichlet process, multi-center, Scleroderma lung study, 2

Suggested Citation

Ho, Man-Wai and Ghosh, Pulak and Elasoff, Robert and Tiwari, Ram, Assessing Treatments Effects in Multi-Center Clinical Trials with Application To Scleroderma Lung Study: A Semiparametric Bayesian Approach (September 11, 2009). IIM Bangalore Research Paper No. 291. Available at SSRN: https://ssrn.com/abstract=2124798 or http://dx.doi.org/10.2139/ssrn.2124798

Man-Wai Ho

National University of Singapore (NUS) ( email )

Bukit Timah Road 469 G
Singapore, 117591
Singapore

Pulak Ghosh (Contact Author)

Indian Institute of Management (IIMB), Bangalore ( email )

Bannerghatta Road
Bangalore, Karnataka 560076
India

Robert Elasoff

University of California, Los Angeles (UCLA) ( email )

405 Hilgard Avenue
Box 951361
Los Angeles, CA 90095
United States

Ram Tiwari

Government of the United States of America - Food and Drug Administration (FDA) ( email )

5600 Fishers Lane
Rockville, MD 20857-0001
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
23
Abstract Views
362
PlumX Metrics